Tale

Changing channels

Daniel Minor Jr.

University of California, San Francisco

Published September 27, 2019

Kissing a frog might not spark a fairy tale ending, but learning how frogs survive some of nature’s most deadly poisons has opened a new chapter in the laboratory of Daniel Minor Jr.

The potent neurotoxin saxitoxin, for example, can come from algae blooms in fresh, brackish, and oceanic waters, such as red tides, which seem to be on the increase from climate change and other factors. The toxin accumulates in clams, oysters, and mussels. If people eat contaminated shellfish, they can die within hours. Saxitoxin has a lethal dose a thousand times smaller than deadly amounts of cyanide or sarin. It is the only marine toxin classified as a chemical weapon.

Importantly for Minor’s research, saxitoxin is believed to exert its deadly effects mainly by blocking sodium channels, paralyzing the muscles needed to breathe.

Bullfrogs, on the other hand, aren’t fazed by the toxin, thanks to a protein they make called saxiphilin. In June 2019, Minor’s University of California, San Francisco, team and their Stanford University collaborators revealed the molecular architecture that allows saxiphilin to sop up the toxin.

The paper in Science Advances describes the molecular shapes and dynamics of saxiphilin alone and bound to saxitoxin. It is the first structural characterization of a “molecular sponge” for a toxin, Minor and his co-authors write. Interestingly, the way the toxin binds to saxiphilin to save the frog is similar to the way the toxin blocks ion channels to poison people.

The atomic structures of the deadly small molecule saxitoxin (right), the saxiphilin protein bound to saxitoxin (left), and an American bullfrog (R. catesbeiana) are superimposed over a red tide. (Credit: Daniel L. Minor, Jr., and Deborah Stalford).

Minor’s research group is interested in ion channels. The tiny pores carry electrical currents into cells that prompt thoughts, sensations, and actions. One system studied in the lab, voltage-gated sodium channels, could lead to new therapeutics for cardiac arrhythmias, movement disorders, pain, migraine, and epilepsy.

But there is another potentially lifesaving angle that Minor had not considered until recently: Preventing and treating poisoning caused by deadly neurotoxins.

“We’re really excited by this auto-resistance mechanism—how an organism deals with a toxic environment and how it survives,” says Minor. His laboratory collection of frogs, toxins, and questions has since expanded. “Poison dart frogs have all these toxins that target sodium channels. Why don’t the frogs kill themselves?”

Minor wants to understand more about how nature has solved the problem of handling these toxins. He also wants to learn how the defensive frog compounds modify sodium channels and use that information to develop new ways to control channel activities in neurons.

The answers have additional public health and commercial implications. The findings may lead to better sensors to screen for toxins in shellfish destined for human consumption. Further work could lead to an antidote for poisoning by toxins in shellfish or chemical weapons.

Having a lab full of frogs wasn’t exactly something Minor had planned, but in high school he was interested in science. In fact, he secretly set his sights on the storied Laboratory for Molecule Biology (LMB) in Cambridge, UK, after reading Freeman Judson’s Eighth Day of Creation about cracking the DNA code.

“To become a scientist was not a normal thing,” says Minor, about his working-class Northeast Pennsylvania hometown. Good students might strive to become doctors or lawyers. His family supported his decision anyway. “But it’s really weird—when I was growing up, our yard faced the yard of another family, and their son also became a scientist. Both [sets of] parents are not sure what happened on this block.”

Daniel Minor at the International Conference on Neurostructural Biology in Beijing in April 2019.

Minor grew up in a family where no one had gone to college and few finished high school. Both grandfathers had worked in the coal mines. The next generation worked in some form of light manufacturing, including Minor’s father, who rose from worker to manager of a factory that made crayons and tempera paints. At age 14, Minor went to work part-time in the factory, loading trucks and mixing pigments with chalky calcium carbonate powder.

Evenings, Minor trained as weightlifter at the local YMCA. He competed in tournaments at the Holy Savior Weight Lifting Club in the basement of a Catholic church near Philadelphia. He specialized in the snatch and the clean and jerk and at age 16 was state powerlifting champion.

As a work-study undergraduate at University of Pennsylvania, Minor avoided slinging hamburgers by finagling jobs in various research labs focusing on proteins, cell biology, and nuclear magnetic resonance. As a graduate student, he joined Peter Kim’s lab at Massachusetts Institute of Technology.

There, he published three Nature papers, the most important showing how much context matters to the way proteins fold. Depending on its amino acid neighbors, for example, the same 11-residue “chameleon sequence” he designed could fold into a beta sheet or a helix. Memorably, Nobel Laureate Max Perutz noted Minor’s discovery in a perspective piece. “That was awesome,” he says.

For his postdoctoral fellowship, Minor was interested in brain and membrane proteins, especially ion channels, a field driven at the time by mutation studies. He wanted to add a structural dimension. That meant either going to a structural lab and being the lone person working on the problem, or joining an ion channel group and being the lone structural person.

In a flurry of indecision, Minor cycled through three labs. He started in Boston and followed a soon-to-be-ex girlfriend to Cambridge, UK. There, he fulfilled a childhood dream as a postdoc at the LMB working with Nigel Unwin for a short period. He reset his postgraduate research at UCSF, where the wife-husband team of Lily and Yuh-Nung Jan were working at the forefront of cloning channels.

“Two things amazed me about Lily,” he says, “She always made time for me, and she mostly thought my ideas were good.” She encouraged Minor to develop a bigger picture perspective, a legacy he wants to pass on to others. There, he built an ion channel skill set portfolio from function to structure and back.

When he moved to San Francisco, Minor dropped his LMB project, a modular approach to the nicotinic acetylcholine receptor. Meanwhile, a talented postdoc who shared a passion for acetylcholine receptors was working in an Amsterdam lab and had found another way to solve a structure of the receptor extracellular domain. They met at a structural biology meeting, bonded over their interest in the nicotinic receptor, and eventually married. Their wedding invitation featured the structure she solved.

“It’s a good lesson,” says Minor, who since age 16 strived to plan ahead thoughtfully and make the right choices. “Here’s an example where my best-laid plans all fell apart, but ended up working out better than I could ever have imagined.”

His good fortune held. He applied for a geneticist job opening in the UCSF Cardiovascular Research Institute. He had worked on yeast genetic selections to study ion channels in the Jan lab, and there are ion channels in the heart. These two factors and a broad view of the search committee led to a job offer. “They just wanted a good scientist working on cardiovascular-related topics,” he says.

Minor began working on ion channels just as other groups had cracked the first ion channel structures, and atomic protein measurements were starting to become relevant to a field that had long relied on mutational and electrophysiology studies. “Their functional relevance took some time to percolate into the field,” he says.

The structure of K2P2.1 (TREK-1) shows modulators and their sites of action, defined structurally (red arrows) or functionally (blue and purple arrows).

His integrated structural approach has shown new ways that protein structure changes affect ion channel activity. For example, a 2017 Nature paper discovered a novel small molecule binding site that props open members of the TREK-1 K2P potassium channel family important for pain, analgesic responses, and mood. “It’s a beautiful example of the need for conformational change to make a binding site,” he says.

Meanwhile, the Minor lab also runs a program to find small molecules that can selectively inhibit ion channels for scientific study and for drug discovery.

The thread that ties the work together is protein chemistry, he says. “We’re trying to understand how proteins work, how they move, how they function, and how we can learn to control their actions.”

-Carol Cruzan Morton

Predicting Proteins

Jens Meiler

Published 25 November 2024

Death Metal

Steven Damo

Published 28 April 2024
Context Matters

Bing Chen

Published 30 January 2024

The Crystal Whisperer

Sarah Bowman

Published 29 November 2023
Data in Motion

Nozomi Ando

Published 29 September 2023

The Monstrous Maw

André Hoelz

Published 28 June 2023
Second Takes

Andrea Thorn

Published 28 February 2023

Radical reactions

Yvain Nicolet

Published 31 January 2023
Floppy Physics

Eva Nogales

Published 30 November 2022

Structure of Equity

Jamaine Davis

Published 28 September 2022
Life and Death of a Cell

Evris Gavathiotis

Published 28 July 2022

Follow the glow

Kurt Krause

Published 29 April 2022
Resolution solutions

Willy Wriggers

Published 25 February 2022

Of enzymes and membranes

Ming Zhou

Published 28 October 2021
Step-by-step

Gabrielle Rudenko

Published 26 September 2021

Moving muscle

Montserrat Samso

Published 26 July 2021
Particle catcher

Stefan Raunser

Published 28 June 2021

Designer drugs

Ho Leung Ng

Published 25 February 2021
Right place, right time

Ernesto Fuentes

Published 29 January 2021

Shape-shifting secrets of membranes

James Hurley

Published 27 November 2020
Enzymatic action

Cynthia Wolberger

Published 28 September 2020

Rules of motion

Priyamvada Acharya

Published 31 July 2020
Cosmic Squared

Michael Cianfrocco

Published 27 June 2020

Kaps are Cool

Yuh Min Chook

Published 28 April 2020
Spiraling into focus

Carsten Sachse

Published 29 March 2020

Seeing cilia

Alan Brown

Published 27 February 2020
For the Love of EM

Guy Schoehn

Published 27 January 2020

Protein Puddles

Michael Rosen

Published 16 December 2019
Changing channels

Daniel Minor Jr.

Published 27 September 2019

Listening Tips

Marcos Sotomayor

Published 30 July 2019
Beyond Cool

Published 31 May 2019

Hao Wu

A Higher Order

Published 30 May 2019
Aye Aye Captain

Alexandre Bonvin

Published 29 April 2019

The PARP Family Family

John Pascal

Published 28 February 2019
Frame by frame

Nikolaus Grigorieff

Published 28 January 2019

Predicting Success

Bil Clemons

Published 18 December 2018
Curiouser and Curiouser

Ramaswamy Subramanian

Published 27 November 2018

Rely on This

Sjors Scheres

Published 26 October 2018
Proteins out of bounds

Gerhard Wagner

Published 27 September 2018

Hiding in plain sight

Gaya Amarasinghe

Published 27 July 2018
Jumping Genes

Orsolya Barabas

Published 27 June 2018

Data Whisperer

Karolin Luger

Published 30 May 2018
Flipping the Switch

Jacqueline Cherfils

Published 27 April 2018

Tooling Around

Andrew Kruse

Published 29 March 2018
Comings and Goings

Tom Rapoport, Ph.D.

Published 23 February 2018

Transcriptional Rhythm

Seth Darst

Published 27 January 2018
The Language of Gene Regulation

Daniel Panne

Published 21 November 2017

Not Your Average Protein

James Fraser

Published 23 October 2017
Message Received

Sebastien Granier

Published 24 August 2017

Resistance is Futile

Celia Schiffer

Published 28 July 2017
Twist of Fate

Leemor Joshua-Tor

Published 28 June 2017

Drug Designer

John Buolamwini

Published 30 May 2017
Mathematically Minded

James Holton

Published 28 April 2017

Garbage Out

Kay Diederichs

Published 30 March 2017
Fixer Upper

Brandt Eichman

Published 27 February 2017

Mobilizers

Phoebe Rice

Published 31 January 2017
Escape Artist

Katya Heldwein

Published 19 December 2016

Nature’s Confectioner

Jochen Zimmer

Published 29 November 2016
State of Fusion

Jason McLellan

Published 27 October 2016

Here Be Dragons

Brian Fox

Published 28 September 2016
SBGrid Assumes Ownership of PyMOLWiki

Published 15 September 2016

Pharm Team

Oleg Tsodikov

Published 24 August 2016
Spiro-Gyra

Alejandro Buschiazzo

Published 27 July 2016

Turning the DIALS

Nicholas Sauter

Published 29 June 2016
Pipeline Dreams

Bridget Carragher and Clint Potter

Published 26 April 2016

U-Store-It

The SBGrid Data Bank provides an affordable and sustainable way to preserve and share structural biology data

Published 28 March 2016
Big Questions, Big Answers

Jennifer Doudna

Published 22 February 2016

Not a Structural Biologist

Enrico Di Cera

Published 17 December 2015
Divide and Conquer

Kevin Corbett

Published 19 November 2015

Computing Cellular Clockworks

Klaus Schulten

Published 23 October 2015
Trans-Plant

Gang Dong

Published 26 September 2015

Keep on Moving

James Berger

Published 23 August 2015
Totally Tubular

Antonina Roll-Mecak

Published 27 July 2015

From Disorder, Function

Julie Forman-Kay

Published 29 June 2015
Into Alignment

Geoff Barton

Published 27 May 2015

Two Labs, Many Methods

Michael Sattler

Published 28 April 2015
Picture This

Georgios Skiniotis

Published 20 March 2015

Intron Intrigue

Navtej Toor

Published 20 February 2015
Cut and Paste

Martin Jinek

Published 28 January 2015

Basics and Beyond

Qing Fan

Published 18 December 2014
Bloodletting and Other Studies

Pedro José Barbosa Pereira

Published 25 November 2014

Wire Models, Wired

A brief history of UCSF Chimera

Published 29 October 2014
In Search of…New Drugs

Doug Daniels

Published 30 September 2014

An Affinity for Affinity…and Corals

John C. Williams

Published 29 August 2014
Pete Meyer, Ph.D.

Research Computing Specialist

Published 22 August 2014

Justin O'Connor

Sr. System Administrator

Published 20 August 2014
Carol Herre

Software Release Engineer

Published 15 August 2014

Elizabeth Dougherty

Science Writer

Published 13 August 2014
Andrew Morin, Ph.D.

Policy Research Fellow

Published 11 August 2014

Jason Key, Ph.D.

Associate Director of Technology and Innovation

Published 8 August 2014
Piotr Sliz, Ph.D.

Principal Investigator, SBGrid

Published 1 August 2014

New Kid on the Block

James Chen

Published 29 July 2014
Membrane Master

Tamir Gonen

Published 30 June 2014

The Natural Bridge

Piotr Sliz

Published 13 June 2014
Surprise, Surprise

Catherine Drennan

Published 26 April 2014

Gone Viral

Olve Peersen

Published 20 March 2014
All Who Wander Are Not Lost

Frank Delaglio

Published 24 February 2014

The Raw and the Cooked

Graeme Winter

Published 24 January 2014
Vacc-elerator

Peter Kwong

Published 17 December 2013

Structural Storyteller

Karin Reinisch

Published 15 November 2013
The Fixer

Jane Richardson

Published 28 October 2013

Inside the Box

Mishtu Dey

Published 17 September 2013
Sensing a Change

Brian Crane

Published 16 August 2013

Towards Personalized Oncology

Mark Lemmon

Published 16 July 2013
Brush with Fame

Yizhi Jane Tao

Published 14 June 2013

Toxic Avenger

Borden Lacy

Published 21 May 2013
Pushing the Boundaries

Stephen Harrison

Published 22 April 2013

Strength in Numbers

Joseph Ho

Published 18 March 2013
One Lab, Many Methods

Wesley Sundquist

Published 12 February 2013

Unplanned Pioneer

Tim Stevens

Published 15 January 2013
From Actin to Action

Emil Pai

Published 11 January 2013

Unstructured

A Brief History of CCP4

Published 12 December 2012
Stop, Collaborate and Listen

Eleanor Dodson

Published 5 November 2012

X-PLORer

Axel Brunger

Published 1 October 2012
Share the Wealth

Zbyszek Otwinowski

Published 22 August 2012

Unraveling RNA

Anna Pyle

Published 18 July 2012
Sharper Image

Pawel Penczek and SPARX

Published 4 June 2012

Creative Copy Cat

Pamela Bjorkman

Published 25 April 2012
Charm and Diplomacy

Gerard Kleywegt

Published 7 March 2012

From Curiosity to Cure

Marc Kvansakul

Published 13 December 2011
The Lure of the Sandbox

Paul Emsley and Coot

Published 15 October 2011

Springsteen, Tolkien, Protein

Alwyn Jones and Frodo

Published 17 June 2011
Structures Solved Simply

Paul Adams and Tom Terwilliger on Phenix

Published 2 June 2011

Playing the Odds

Randy Read and Phaser

Published 19 May 2011
Escape from the Darkroom

Wolfgang Kabsch and XDS

Published 19 May 2011

Crystallography for Kids

Lynne Howell

Published 17 May 2011
Better, Faster, Stronger, More

Victor Lamzin and ARP/wARP

Published 17 May 2011

Side-Track to Success

Ning Zheng

Published 13 May 2011

Predicting Proteins

Death Metal

Context Matters

The Crystal Whisperer

Data in Motion

The Monstrous Maw

Second Takes

Radical reactions

Floppy Physics

Structure of Equity

Life and Death of a Cell

Follow the glow

Resolution solutions

Of enzymes and membranes

Step-by-step

Moving muscle

Particle catcher

Designer drugs

Right place, right time

Shape-shifting secrets of membranes

Enzymatic action

Rules of motion

Cosmic Squared

Kaps are Cool

Spiraling into focus

Seeing cilia

For the Love of EM

Protein Puddles

Changing channels

Listening Tips

Beyond Cool

Hao Wu

Aye Aye Captain

The PARP Family Family

Frame by frame

Predicting Success

Curiouser and Curiouser

Rely on This

Proteins out of bounds

Hiding in plain sight

Jumping Genes

Data Whisperer

Flipping the Switch

Tooling Around

Comings and Goings

Transcriptional Rhythm

The Language of Gene Regulation

Not Your Average Protein

Message Received

Resistance is Futile

Twist of Fate

Drug Designer

Mathematically Minded

Garbage Out

Fixer Upper

Mobilizers

Escape Artist

Nature’s Confectioner

State of Fusion

Here Be Dragons

SBGrid Assumes Ownership of PyMOLWiki

Pharm Team

Spiro-Gyra

Turning the DIALS

Pipeline Dreams

U-Store-It

Big Questions, Big Answers

Not a Structural Biologist

Divide and Conquer

Computing Cellular Clockworks

Trans-Plant

Keep on Moving

Totally Tubular

From Disorder, Function

Into Alignment

Two Labs, Many Methods

Picture This

Intron Intrigue

Cut and Paste

Basics and Beyond